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1. Introduction
   Enterococci are commensal Gram-positive bacteria that 
inhabit in oral cavity, gastrointestinal tract, and vagina of 
humans and animals[1]. These bacteria can cause a wide 
variety of diseases in humans, especially, nosocomial 
infections and they now rank among the leading causative 
pathogens in the world[2]. Enterococcus faecalis (E. faecalis) 
is responsible for up to 90% of human enterococcal 
infections[3], its pathogenicity ranges from life threatening 
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Objective: To evaluate some essential oils in treatment of intractable oral infections, principally 
caused by biofilm of multidrug-resistant Enterococcus faecalis (E. faecalis), such as persistent 
endodontic infections in which their treatment exhibits a real challenge for dentists. 
Methods: Ten chemically analyzed essential oils by gas chromatography-mass spectrometry 
were evaluated for antimicrobial activity against sensitive and resistant clinical strains of E. 
faecalis in both planktonic and biofilm state using two methods, disk diffusion and broth micro-
dilution.
Results: Studied essential oils showed a good antimicrobial activity and high ability in E. 
faecalis biofilm eradication, whether for sensitive or multidrug-resistant strains, especially 
those of Origanum glandulosum and Thymbra capitata with interesting minimum inhibitory 
concentration, biofilm inhibitory concentration, and biofilm eradication concentration values 
which doesn’t exceed 0.063%, 0.75%, and 1.5%, respectively. 
Conclusions: Findings of this study indicate that essential oils extracted from aromatic plants 
can be used in treatment of intractable oral infections, especially caused by biofilm of multidrug-
resistant E. faecalis. 
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This study evaluated some EOs in 
treatment of intractable oral infections, 
principally caused by biofilm of 
multidrug-resistant E. faecalis. The 
results of this study is useful for E. 
faecalis infection treatment. The high 
yield and strong antimicrobial activity 
of three Algerian medicinal plants EOs 
used in eradication of MDR pathogens 
from oral ecosystem may contribut 
to the medical treatment for oral 
intractable infections caused by E. 
faecalis.
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diseases in compromised individuals to less severe 
conditions particularly due to many virulence factors[4]. 
Enterococci are multidrug-resistant (MDR) bacteria to most 
antimicrobial drugs used to treat human infections which 
exhibit a considerable therapeutic challenges[5]. 
   In oral cavity, E. faecalis is not considered to be part 
of the normal oral microbiota[6]. E. faecalis is mainly 
responsible for several oral pathologies, particularly, dental 
caries[7], dental abscess[8], periodontal infections[9], apical 
periodontitis[10], and persistent endodontic infections, also 
known as post-treatment endodontic diseases, in which E. 
faecalis is the etiological causative agent and responsible 
for serious complications[11,12]. This can be explained by the 
fact that this bacterium possesses not only many virulence 
factors, but also an endogenous resistance to extreme 
ecological conditions and antimicrobials[8], allowing E. 
faecalis to tolerate harsh environmental conditions in some 
sites within oral cavity, especially in root canal[11].
   The resistance of microorganisms to harsh conditions 
is due to biofilm formation[13], a complex of lifestyle that 
allowing bacteria displaying specific properties, including 
an increase in resistance to antibiotics and antiseptic 
chemicals[14]. In fact, formation of these sessile communities 
and their inherent resistance to biocides are the origin 
of many persistent and chronic bacterial infections[15]. In 
dental root canal, eradication of E. faecalis with chemo-
mechanical preparations and using antiseptics is difficult[11]. 
Even the most used antiseptics in endodontic treatments, 
sodium hypochlorite and chlorhexidine showed low ability 
to eliminate E. faecalis[16].
   The lack of strategies for E. faecalis biofilm elimination 
requires trying other substances except antiseptics and 
antibiotics, such as secondary metabolites of plants, 
especially, essential oils (EOs) one of the most important 
bioactive substances in medicinal plants[17]. Possessing a 
good antimicrobial activity[18], EOs can replace treatments 
with antibiotics and disinfection using antiseptics. 
Furthermore, EOs have many interesting medicinal properties 
which can contribute to the treatment of intractable oral 
infections such as anti-inflammatory[19,20], anti-oxidant and 
stimulating the immune system response activities[21,22].
   Treatment of oral infections by plant preparations, 
such as decoctions and infusions, is very popular among 
Arab peoples. Major reason of using those herbs extracts 
is their effectiveness and availability. In Algeria, many 
herbs especially from Lamiaceae family are widely used 
in treatment of oral diseases such as candidiasis, dental 
caries and periodontal diseases. Present principally in wild, 
species of thyme, lavender, oregano and rosemary are even 
applied by local population as antiseptics and for oral cavity 
aromatization because of their refreshing scent.   
   In the lack of studies that evaluate EOs as treatments of 
intractable oral infections, such as persistent endodontic 
infections, the aim of this study was to evaluate some 
Algerian EOs as natural antiseptics and antimicrobials 
against MDR E. faecalis, one of the principal oral pathogens, 
in both planktonic and biofilm state.
2. Materials and methods 
2.1. Plant material 
   We have selected ten medicinal plants for this study 
which are presented in Table 1. The choice of plant species 
is based on their use by the local population against oral 
infections, such as periodontal infections and dental 
caries. All species have been harvested from the region of 
Table 1
Data on the studied plant material.
Scientific name Family Studied organs Harvest station Harvest date
Name (Municipality) Location Altitude (m)
Ammi visnaga (L.) Lam. Apiaceae Leaves, Stems, Flowers & Seeds Bouhannak (Mansoura) +34°88’19” 711 Jul-11
- 1°37’07”
Ammoides verticillata (Desf.) Briq. Apiaceae Leaves, Stems, Flowers & Seeds Atar (Mansoura) +34°88’51” 980 Jul-11
-1°37’75”
Artemisia arborescens (Vaill.) L. Asteraceae Leaves, Stems & Flowers Sidi Yahyia (Sidi Medjahed) +34°46’45” 380 Jul-11
-1°38’12”
Dittrichia graveolens (L.) Greuter Asteraceae Leaves, Stems & Flowers Bouhannak (Mansoura) +34°88’14” 725 Aug-11
-1°36’38”
Lavandula dentata L. Lamiaceae Leaves, Stems & Flowers Sidi Yahyia (Sidi Medjahed) +34°88’14” 580 Jul-11
-1°36’38”
Lavandula multifida L. Lamiaceae Leaves, Stems & Flowers Bouhannak (Mansoura) +34°88’51” 700 Oct-11
-1°37’75”
Mentha piperita L. Lamiaceae Leaves, Stems & Flowers Ouled charef (Maghnia) +34 °49’57” 400 May-12
-1°42’4”
Origanum vulgare subsp. glandulosum (Desf.) Ietsw. Lamiaceae Leaves, Stems & Flowers Atar (Mansoura) +34°88’51” 980 Jun-11
-1°37’75”
Rosmarinus eriocalyx Jord. & Fourr. Lamiaceae Leaves, Stems & Flowers Honaine +34°88’14” 100 Jun-11
-1°36’38”
Thymbra capitata (L.) Cav. Lamiaceae Leaves, Stems & Flowers El Koudia +34°53’59” 690 Jul-11
-1°21’55”
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Tlemcen located in the northwestern Algeria, from Jun 2011 
to May 2012, in the wild and others cultivated. Specimens 
of all species in this study were identified by Laboratory of 
Ecology and Management of Natural Ecosystems, University 
of Tlemcen. All voucher specimens were deposited in our 
laboratory.
2.2. Obtaining EOs
   For this purpose, we have used hydrodistillation with 
Clevenger-type apparatus of the fresh plant material, as 
recommended by Benbelaïd et al[23]. Recovered EOs were 
dried using magnesium sulfate and stored in smoked vials at 
4 °C until analysis.
2.3. EOs analysis with GC and GC/MS
   Gas chromatography (GC) analysis was performed using 
a Perkin Elmer Autosystem GC-type chromatograph, 
equipped with two flame ionization detectors, for the 
detection of volatile compounds, one injector/splitter, and 
two polar (Rtx-Wax, polyethylene glycol) and nonpolar 
(Rtx-1, polydimethylsiloxane) columns (60 m伊0.22 mm inner 
diameter, film thickness 0.25 µm). The carrier gas was 
helium (1 mL/min) with a column head pressure of 25 psi. 
The injector temperature was 250 °C and that of the detector 
was 280 °C. The temperature was programmed to increase 
from 60 to 230 °C at the rate of 2 °C/min, and then maintained 
constant for 45 min at a level of 230 °C. The injection was 
done by split mode with a split ratio of 1/50. The amount of 
EO injected was 0.2 µL. Quantification was made by direct 
electronic integration of peak areas.
   For the gas chromatography-mass spectrometry (GC/MS), 
analysis was performed using a Perkin Elmer Autosystem 
XL chromatograph, with an automatic injector and two 
polar (Rtx-Wax) and nonpolar (Rtx-1) columns (60 m伊0.22 
mm inner diameter, film thickness 0.25 µm), coupled with 
a Perkin Elmer TurboMass mass detector. The carrier gas 
was helium (1 mL/min) with a column head pressure of 25 psi. 
The injector temperature was 250 °C. The temperature was 
programmed to rise from 60 to 230 °C at the rate of 2 °C/min, and 
then kept constant for 35 min at a level of 230 °C. The injection 
was done by split mode with a split ratio of 1/80. The amount 
of EO injected was 0.2 µL. Detection was carried out by a 
quadrupole analyzer which consisted of an assembly of 
four parallel electrodes with cylindrical section. The source 
temperature was 150 °C. The device functioned in electron 
impact and fragmentation was performed at an electric field 
of 70 eV. The resulting mass spectra were acquired over the 
mass range of 35-350 Da.
   To identify the constituents of the studied EOs, 
identification made by Kovats index was used, where the 
polar and nonpolar retention indices were calculated from 
the retention times of a series of n-alkanes, and from 
databases of mass spectra, where the obtained mass spectra 
were compared with those of computerized libraries[24].
2.4. Microbial strains
   Seven strains of E. faecalis have been selected for this 
study; two of them are American Type Culture Collection 
strains with codes ATCC 29212 and ATCC 49452 (sensitive 
to antibiotics), while the rest are multidrug-resistant 
strains, selected from a collection of clinical E. faecalis 
strains obtained from patients with various oral infections, 
including, apical periodontitis, chronic periodontitis, 
aggressive periodontitis, and cervicofacial cellulitis which 
are summarized in Table 2. Strain samples were taken in 
the service of stomatology at University Health Center of 
Tlemcen from December 2011 to June 2012. At the first time, 
samples were enriched in Roth broth (Conda PronadisaTM, 
Spain) at 37 °C for 18 h. Thus, positive culture was inoculated 
in bile esculin agar (Fluka®, Switzerland) and incubated 
at 37 °C for 24 h, in order to isolate pure colonies. After 
purification, all isolated strains of E. faecalis were firstly 
identified by conventional microbiological methods, while 
the final identification confirmation was carried out by API 
Strep® gallery (BioMérieux®, France). Finally, all E. faecalis 
strains were conserved in brain heart infusion broth (Conda 
PronadisaTM, Spain) with glycerol (Fluka®, France) (8:2,v/v) at 
-20 °C.
Table 2
Data on studied E. faecalis strains.
Strains Origin
Antibiotics
GN C VA E CIP AX TE
1 Apical periodontitis R R R R R S R
2 Apical periodontitis R R R R R S R
3 Cervicofacial cellulitis R S R R S S R
4 Aggressive periodontitis R R R R S S R
5 Chronic periodontitis R R R S S S R
GN: Gentamicin; C: Chloramphenicol; VA: Vancomycin; E: Erythromycin; CIP: 
Ciprofloxacin; AX: Amoxicillin; TE: Tetracycline. R: Resistant; S: Sensitive. 
2.5. Antibiogram
   For selection of E. faecalis multidrug-resistant strains 
from clinical collection, we have performed an antibiogram 
according to Clinical and Laboratory Standards Institute 
(CLSI) recommendations[25]. Antibiogram was determined with 
the following antimicrobial agent-containing disks: amoxicillin 
(25 µg), chloramphenicol (30 µg), ciprofloxacin (5 µg), 
erythromycin (15 µg), gentamicin (15 µg), tetracycline (30 µg) 
and vancomycin (30 µg) (Oxoid®, England).
2.6. Antimicrobial assay
2.6.1. Inocula preparation
   Previously identified and conserved strains were taken and 
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inoculated in Mueller-Hinton broth (Fluka®, India). After 
incubation at 37 °C for 24 h, suspensions were taken and 
shaken well using the vortex then diluted for standardizing. 
Inocula were set to 0.5 McFarland or an optical density from 0.08 to 
0.13 at 625 nm wavelength, which corresponds to 108 CFU/mL[25].
2.6.2. Antimicrobial activity of EOs against planktonic E. 
faecalis strains  
2.6.2.1. Disk diffusion method
   We have used Kirby-Bauer’s agar disk diffusion modified 
method[26], where antimicrobial activity of EOs against 
E. faecalis strains was evaluated in plates with Mueller-
Hinton agar (Fluka®, India) pre-inoculated by swabbing of 
standardized microbial suspension at 108 CFU/mL. Whatman 
No. 3 paper disks impregnated with 10 µL of EO, were placed 
on the surface of agar, each disk has a 6 mm diameter. 
After incubation at 37 °C for 24 h, the results were read by 
measuring the diameter of inhibition zones in millimeters 
(mm) by vernier scale. All tests were performed in triplicate.
2.6.2.2. MIC determination
   The minimum inhibitory concentrations (MICs) of EOs were 
determined by modified broth micro-dilution method from 
Wiegand et al[27]. Briefly, concentrations of each EO were 
prepared by 1/2 dilution series in Mueller-Hinton broth with 
1% of Tween 80, starting from 40.00% to 0.08%. After that, 
96-well microplate was filled by distributing 90 µL of 5伊
10
5 CFU/mL inoculum (prepared by 1/200 dilution of 108 CFU/
mL inoculum) with 10 µL of each concentration. The final 
concentration of EOs in wells was ranging from 4% to 0.008%, 
and the final concentration of Tween 80 was 0.1% in each 
well. After 24 h incubation at 37 °C, the MIC was defined as 
the lowest concentration of EO inhibiting visible growth. In 
addition, two wells of every range of microplate were filled 
with inoculum and inoculum with 0.1% of Tween 80, and 
served as positive controls for each strain. All tests were 
performed in triplicate.
2.6.3. Antimicrobial activity of EOs against E. faecalis strains 
in biofilm
2.6.3.1. Biofilm inhibitory concentration
   The biofilm inhibitory concentrations (BICs) of studied EOs 
against E. faecalis strains in biofilm case were determined 
as described by Nostro et al.[28] with modification. Firstly, 
96-well microplate was filled by distributing 100 µL of 
inoculum at 108 CFU/mL in each well. After 24 h of incubation 
at 37 °C, medium was gently removed and all wells were 
washed three times with sterile phosphate buffered saline. 
In the same moment, ten concentrations of each EO were 
prepared by 1/2 dilution series in Mueller-Hinton broth 
with 3.33% of Tween 80, starting from 40.00% to 0.08%. After 
removing of planktonic cells from microplate, all wells were 
filled with 70 µL of sterile Mueller-Hinton broth with 30 µL 
of each concentration, the final concentrations of EO in wells 
were ranging from 12% to 0.02%, and the final concentration 
of Tween 80 was about 1% in each well. Biofilm inhibitory 
concentration was determined after 24 h incubation at 37 °C, 
as the lowest concentration with no culture in well, visually 
determined and confirmed by no increase in optical density 
compared with the initial reading. Two ranges of wells for 
each microplate were filled with sterile Mueller-Hinton 
broth and serve as positive controls. All tests were performed 
in triplicate.
2.6.3.2. Biofilm eradication concentration
   Biofilm eradication concentration (BEC) is the lowest 
concentration of EO that kills all viable cells of E. faecalis 
present and protected in biofilm. BEC was defined also as 
described by Nostro et al.[28]with modification. Protocol 
was continued in the same 96-well microplate used in 
determination of BIC, in the same day where the result of 
BIC was read. Supernatant fluid was gently removed and the 
wells were well washed three times with sterile phosphate 
buffered saline and one time with 20% sterile ethanol 
solution (Scharlau®, Spain) (in order to eliminate remaining 
traces of EOs). Then, microplate wells were filled with sterile 
tryptic soy agar (Conda PronadiaTM, Spain) and incubated for 
72 h at 37 °C. BEC was determined as the lowest concentration 
with no culture visually determined and confirmed by 
no increase in optical density compared with the initial 
reading. Positive control was performed to verify that 20% of 
ethanol has no effect on strains. All tests were performed in 
triplicate.
2.7. Statistical analysis
   Statistical analyses used in this study have been carried 
out using Microsoft® Excel. Where, comparison between 
antimicrobial activity against reference and clinical strains 
was performed by Student t-test at 95% level (P<0.05) in both 
planktonic and biofilm state. 
3. Results
3.1. Chemical composition of studied EOs
   Quantitative and qualitative analytical results of the 
studied EOs by GC and GC/MS are shown in Table 3. In 
which we notice variability in composition of EOs between 
studied plants. EOs of species which belong to Lamiaceae 
and Apiaceae family are mainly rich in oxygenated 
monoterpenes, especially alcohols, such as thymol, 
carvacrol, and linalool with a high percentage. Thymbra 
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Table 3
Chemical composition of studied EOs.
# Component nRI pRI Chemical composition (%) ID
1 2 3 4 5 6 7 8 9 10
1 Santolina triene 901 1018 0.70 RI, MS
2 Isobutyl isobutyrate 902 1090 2.27 RI, MS
3 Tricylene 921 1020 0.68 RI, MS
4 alpha-Thujene 922 1023 1.55 0.33 0.33 1.02 2.07 RI, MS
5 alpha-Pinene 931 1022 1.90 1.04 0.90 0.88 4.86 1.12 0.74 11.68 1.07 RI, MS
6 Camphene 943 1066 6.03 0.91 0.11 11.64 0.48 RI, MS
7 1-Octen-3-ol 959 1446 0.56 0.17 0.99 RI, MS
8 Octan-3-one 963 1253 0.13 RI, MS
9 Sabinene 964 1120 2.25 1.87 1.51 0.38 RI, MS
10 beta-Pinene 970 1110 0.11 1.19 13.89 0.42 0.51 0.19 2.77 0.54 RI, MS
11 Myrcene 979 1159 0.57 2.28 0.93 0.57 1.98 0.71 2.39 RI, MS
12 Dehydro-1,8-cineole 979 1197 1.29 RI, MS
13 Isobutyl isovalerate 993 1175 3.23 RI, MS
14 alpha-Phellandrene 997 1164 0.26 0.26 0.54 RI, MS
15 2-Methyl butyl isobutyrate 1004 1176 10.27 RI, MS
16 delta-3-Carene 1005 1147 0.1 0.48 RI, MS
17 alpha-Terpinene 1008 1178 0.13 0.64 2.76 1.54 RI, MS
18 para-Cymene 1011 1268 1.71 15.58 2.77 17.07 1.83 8.58 RI, MS
19 Limonene 1020 1199 1.80 15.02 0.58 0.58 RI, MS
20 1,8-Cineole 1020 1209 0.51 36.72 1.26 5.57 15.31 RI, MS
21 cis-beta-Ocimene 1024 1230 1.59 0.11 RI, MS
22 trans-beta-Ocimene 1034 1247 1.78 0.13 RI, MS
23 gamma-Terpinene 1047 1243 6.63 1.14 27.03 0.35 5.67 RI, MS
24 trans-Sabinene hydrate 1051 1451 1.75 0.17 0.11 1.80 RI, MS
25 Linalool oxide 1057 1435 1.34 0.53 RI, MS
26 alpha-Thujone 1067 1395 1.44 RI, MS
27 Fenchone 1071 1401 3.78 0.83 0.32 RI, MS
28 Terpinolene 1078 1280 0.13 1.10 0.56 0.10 0.30 RI, MS
29 Linalool 1081 1544 35.57 0.11 0.80 3.11 51.59 0.66 0.30 0.57 RI, MS
30 2-Methyl butyl isovalerate 1098 1274 14.14 RI, MS
31 beta-Thujone 1103 1422 47.58 RI, MS
32 Camphor 1123 1517 0.91 35.50 RI, MS
33 trans-Pinocarveol 1125 1651 5.76 RI, MS
34 trans-Verbenol 1129 1676 2.02 RI, MS
35 Pinocarvone 1136 1558 2.35 RI, MS
36 delta-Terpineol 1143 1658 1.53 RI, MS
37 Borneol 1148 1698 1.05 19.48 2.04 0.12 2.03 1.07 RI, MS
38 Cryptone 1157 1667 2.30 RI, MS
39 Terpinen-4-ol 1161 1600 0.18 3.26 0.96 0.11 2.11 5.16 RI, MS
40 Myrtenal 1172 1628 4.12 RI, MS
41 Estragole 1176 1670 4.49 RI, MS
42 Myrtenol 1177 1789 3 RI, MS
43 alpha-Terpineol 1179 1700 0.14 0.83 1.82 1.51 6.87 0.16 0.47 RI, MS
44 trans-Carveol 1196 1832 1.09 RI, MS
45 Cuminaldehyde 1217 1782 1.14 RI, MS
46 Carvone 1222 1739 1.17 RI, MS
47 Carvacrol methyl ether 1231 1603 0.84 RI, MS
48 Geraniol 1232 1844 3.15 RI, MS
49 Linalyl acetate 1240 1557 21.12 RI, MS
50 Thymol 1266 2189 50.13 41.62 RI, MS
51 Bornyl acetate 1269 1515 56.16 0.33 RI, MS
52 Perillyl alcohol 1276 2005 0.86 RI, MS
53 Carvacrol 1278 2219 8.81 0.92 57.75 2.15 58.68 RI, MS
54 Eugenol 1330 2171 0.41 RI, MS
55 alpha-Terpinyl acetate 1334 1695 0.15 RI, MS
56 Neryl acetate 1342 1725 2.26 RI, MS
57 Methyl eugenol 1367 2009 0.16 RI, MS
Results are in percentage (%) of components for EOs of (1) A. visnaga, (2) A. verticillata, (3) A. arborescens, (4) D. graveolens, (5) L. dentata, (6) L. multifida, (7) M. 
piperita, (8) O. vulgare subsp. glandulosum, (9) R. eriocalyx, and (10) T. capitata. Percentages and elution order of individual components are given on nonpolar 
column. Retention indices nRI and pRI are given respectively on nonpolar (Rtx-1) and polar (Rtx-Wax) columns. ID: identification method by comparison of RI 
and MS. RI: Retention indices; MS: Mass spectra.
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Table 3, continued
Chemical composition of studied EOs.
# Component nRI pRI Chemical composition (%) ID
1 2 3 4 5 6 7 8 9 10
58 alpha-Ylangene 1375 1476 0.16 RI, MS
59 gamma-Caryophyllene 1407 1571 1.91 1.70 RI, MS
60 Neryl acetone 1410 1825 0.51 RI, MS
61 3-Buten-1-ol, 3-methyl-, benzoate 1422 1979 0.88 RI, MS
62 beta-Caryophyllene 1424 1591 0.58 1.86 0.96 RI, MS
63 beta-Farnesene 1448 1661 0.09 RI, MS
64 alpha-Humulene 1456 1665 0.12 RI, MS
65 Germacrene D 1478 1710 13.85 0.10 RI, MS
66 beta-Bisabolene 1500 1720 22.91 0.14 RI, MS
67 Cadinene D 1516 1725 0.30 RI, MS
68 beta-Sesquiphellandrene 1516 1765 0.57 RI, MS
69 Spathulenol 1560 2119 1.58 RI, MS
70 Caryophyllene oxide 1576 1980 2.56 1.24 0.18 0.46 RI, MS
71 Caryophyllen-4(14),8(15)-dien-5α-ol 1624 2155 1.06 RI, MS
72 T-Cadinol 1632 2169 0.93 0.20 RI, MS
73 beta-Eudesmol 1640 2230 0.81 RI, MS
74 alpha-Cadinol 1645 2231 0.94 RI, MS
75 Intermedeol 1647 2215 0.63 RI, MS
76 alpha-Bisabolol 1672 2217 0.50 RI, MS
77 Chamazulene 1713 2410 13.39 RI, MS
78 Geranyl linalool 2026 2444 6.06 RI, MS
Yield (% v/w) 0.7 1.7 1.3 0.8 1.8 0.4 1.5 2.3 1.9 1.9
Total identified (%) 92.39 98.91 94.22 94.28 94.72 95.71 92.88 99.44 90.76 92.85
Monoterpene hydrocarbons 12.58 39.54   7.93   9.38 21.17 5.8   1.79 52.18 33.70 22.88
Oxygenated monoterpenes 39.35 59.37 59.05 76.93 72.16 62.07 91.09 44.99 56.76 67.28
Sesquiterpene hydrocarbons 27.24   5.53   0.58 24.86   1.79   0.56  1.70
Oxygenated sesquiterpenes   1.56   0.81   2.86   0.18   2.61
Others 40.46   0.88   0.16   0.30   0.41   0.99
Results are in percentage (%) of components for EOs of (1) A. visnaga, (2) A. verticillata, (3) A. arborescens, (4) D. graveolens, (5) L. dentata, (6) L. multifida, (7) M. 
piperita, (8) O. vulgare subsp. glandulosum, (9) R. eriocalyx, and (10) T. capitata. Percentages and elution order of individual components are given on nonpolar 
column. Retention indices nRI and pRI are given respectively on nonpolar (Rtx-1) and polar (Rtx-Wax) columns. ID: identification method by comparison of RI 
and MS. RI: Retention indices; MS: Mass spectra.
Table 4
Inhibition effect of studied EOs against planktonic E. faecalis strains. Expressed by the diameter inhibition zones (IZ in mm) and minimum inhibitory 
concentration (MIC in % v/v) methods.
Species  R1 R2 Strain 1 Strain 2 Strain 3 Strain 4 Strain 5
A. visnaga IZ 10依1 11依0 11依1 11依 0 10依1 11依0 10依1
MIC 4.000依0.000 4.000依0.000 4.000依0.000 2.000依0.000 4.000依0.000 4.000依0.000 4.000依0.000
A. verticillata IZ 35依1 34依1 36依1 35依1 35依2 35依1 34依1
MIC 0.250依0.000 0.208依0.072 0.250依0.000 0.250依0.000 0.250依0.000 0.208依0.072 0.250依0.000
A. arborescens IZ 10依1 11依0 11依1 11依1 10依0 11依1 11依0
MIC 4.000依0.000 4.000依0.000 4.000依0.000 3.333依1.154 4.000依0.000 4.000依0.000 4.000依0.000
D. graveolens IZ 12依1 13依1 13依0 13依1 13依0 13依1 12依1
MIC 4.000依0.000  4.000依0.000 2.000依0.000 2.000依0.000 4.000依0.000 3.333依0.154 4.000依0.000  
L. dentata IZ 15依0 16依1 15依1 16依1 15依1 16依1 15依1
MIC 1.000依0.000 0.833依0.288 0.666依0.288 0.500依0.000 1.000依0.000 1.000依0.000 1.000依0.000
L. multifida IZ 26依1 26依1 27依1 27依1 26依1 26依1 26依1
MIC 0.250依0.000  0.250依0.000   0.250依0.000  0.208依0.072  0.250依0.000 0.250依0.000  0.250依0.000
M. piperita IZ 9依1 9依0 10依0 11依1 10依0 10依1 9依0
MIC 2.000依0.000 2.000依0.000 2.000依0.000 1.666依0.057 2.000依0.000 2.000依0.000 2.000依0.000
O. vulgare subsp. 
glandulosum 
IZ 28依1 29依1 29依1 29依1 28依1 29依1 28依1
MIC 0.063依0.000 0.063依0.000 0.026依0.009 0.026依0.009 0.063依0.000 0.032依0.000 0.063依0.000
R. eriocalyx IZ 13依1 13依0 13依1 13依2 13依0 13依0 12依1
MIC 1.000依0.000  1.000依0.000 1.000依0.000 0.833依0.288 1.000依0.000 1.000依0.000 1.333依0.057 
T. capitata IZ 30依1 31依1 32依1 32依1 31依1 31依1 30依1
MIC 0.052依0.018 0.063依0.000 0.063依0.000 0.052依0.018 0.063依0.036 0.063依0.000 0.063依0.000
All results are mean依SD of three repeats. R1: E. faecalis ATCC 29212; R2: E. faecalis ATCC 49452. -: not determined.
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4. Discussion
   In the present study, we have evaluated some Algerian 
EOs against oral MDR E. faecalis. The choice of this species 
is based on many factors. Firstly, because of its multiple 
virulence factors[29], the presence of this Gram-positive 
bacterium in the oral cavity has, in fact, a relation with 
several dental diseases, especially apical periodontitis[10]. 
In a research released by Salah et al.[30] all E. faecalis 
isolates in their study were recovered only from patients 
with dental diseases, especially necrotic pulps, while no E. 
faecalis strains were found in healthy patients. Secondly, E. 
faecalis is a nosocomial bacterium which can resist against 
many antibiotics[31], chemo-mechanical preparations, and 
Table 5
Inhibition effect of studied EOs against strains of E. faecalis in biofilm. Expressed by biofilm inhibitory concentration (BIC in %v/v) and biofilm eradication 
concentration (BEC in %v/v) methods.
Species  R1 R2 Strain 1 Strain 2 Strain 3 Strain 4 Strain 5 
A. visnaga
BIC 6.00依0.00 6.00依0.00     12.00依0.00     12.00依0.00 6.00依0.00     12.00依0.00 6.00依0.00
BEC 6.00依0.00 6.00依0.00 - -     12.00依0.00 -      12.00依0.00 
A. verticillata
BIC 0.38依0.00 0.38依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00
BEC 0.75依0.00 0.75依0.00 2.00依0.86 3.00依0.00 1.50依0.00 3.00依0.00 1.50依0.00 
A. arborescens 
BIC 6.00依0.00 6.00依0.00 - - 12.00依0.00 -      12.00依0.00
BEC  12.00依0.00     12.00依0.00 - - - -  -
D. graveolens
BIC 6.00依0.00 6.00依0.00 6.00依0.00 6.00依0.00 6.00依0.00 6.00依0.00 6.00依0.00
BEC 6.00依0.00 6.00依0.00 8.00依3.46     12.00依0.00  6.00依0.00     12.00依0.00 6.00依0.00 
L. dentata
BIC 1.50依0.00 1.50依0.00 3.00依0.00 4.00依1.73 3.00依0.00 3.00依0.00 3.00依0.00
BEC 3.00依0.00 3.00依0.00 6.00依0.00 6.00依0.00  6.00依0.00 6.00依0.00 6.00依0.00 
L. multifida
BIC 0.38依0.00 0.50依0.21 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00
BEC 0.75依0.00 0.75依0.00 2.00依0.86 3.00依0.00 2.50依0.86 3.00依0.00 1.50依0.00
M. piperita
BIC 1.50依0.00 1.50依0.00 3.00依0.00 3.00依0.00 3.00依0.00 3.00依0.00 3.00依0.00 
BEC 3.00依0.00 3.00依0.00 6.00依0.00 6.00依0.00  6.00依0.00 6.00依0.00 3.00依0.00 
O. vulgare subsp. glandulosum
BIC 0.38依0.00 0.38依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00
BEC 0.75依0.00 0.63依0.22 1.50依0.00 1.50依0.00 1.00依0.43 1.50依0.00 0.75依0.00 
R. eriocalyx 
BIC 3.00依0.00 3.00依0.00 6.00依0.00 6.00依0.00 3.00依0.00 6.00依0.00 3.00依0.00
BEC 6.00依0.00 6.00依0.00 - -     12.00依0.00 -      12.00依0.00
T. capitata
BIC 0.38依0.00 0.38依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00 0.75依0.00 
BEC 0.63依0.21 0.75依0.00 1.50依0.00 1.50依0.00 1.25依0.43 1.50依0.00 1.00依0.43
All results are mean依SD of three repeats. R1: E. faecalis ATCC 29212; R2: E. faecalis ATCC 49452. -: not determined.
capitata (T. capitata) and Lavandula multifida (L. multifida) 
are constituted principally by carvacrol (58.68% and 57.75%, 
respectively), beta-bisabolene (22.91%) is the second major 
component in L. multifida EOs. Thymol followed by gamma-
terpinene and para-cymene are the main constituents in 
EO of Origanum glandulosum (O. glandulosum) (41.62%, 
27.03%, and 17.07%, respectively), and thymol followed by 
para-cymene and limonene in EO of Ammoides verticillata 
(A. verticillata) (50.13%, 15.58%, and 15.02%, respectively). 
Linalool and linalyl acetate (51.59% and 21.12%, respectively) 
are the major constituents of Mentha piperita (M. piperita). 
While the rest of studied EOs are constituted principally by 
non-alcoholic terpenes, such as beta-thujone (47.58%) in 
Artemisia arborescens (A. arborescens), bornyl acetate (56.16%) 
in Dittrichia graveolens (D. graveolens), 1,8-cineole (36.72%) 
in Lavandula dentata (L. dentata), and camphor (35.50%) in 
Rosmarinus eriocalyx (R. eriocalyx).
3.2. Antimicrobial activity of EOs against MDR E. faecalis
   During sampling at the Service of Dentistry at University 
Health Center of Tlemcen, we have remarked that E. faecalis 
was responsible for several oral complications, especially, 
apical periodontitis. Antibiogram results of E. faecalis 
strains have shown that almost all of these bacteria are 
multidrug-resistant to majority of antibiotics, especially 
vancomycin and gentamicin, only amoxicillin was effective 
on all these E. faecalis strains.
   Antimicrobial activity evaluation of studied EOs against E. 
faecalis strains was very interesting, whether in planktonic 
or biofilm state. In planktonic, both methods, agar disk 
diffusion and MIC determination (Table 4), have shown 
that EOs of T. capitata and O. glandulosum were the most 
active, with inhibition zone larger than 27 mm and MIC less 
than 0.07% whether for susceptible or resistant strains. At 
less degree, A. verticillata, L. multifida, L. dentata, and M. 
piperita have a good antimicrobial activity on all strains, 
while the rest of EOs have shown a moderate activity.
   In biofilm state (Table 5), both EOs of T. capitata and 
O. glandulosum were also the effective oils, which can 
inhibit biofilm growth of all E. faecalis strains at 0.75%, 
and can eradicate all viable microbial cells protected in 
biofilm at 1.50% only. Other EOs have shown an interesting 
antimicrobial activity against E. faecalis strains in biofilm, 
notably A. verticillata and L. multifida with their BECs range 
between 1.50% and 3.00%.
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antiseptics, which represent a real challenge for dentists 
in some intractable infections, as seen in post-treatment 
endodontic diseases[11]. Thirdly, E. faecalis has an ability 
to form biofilm which seems to be a key factor in many 
bacterial infections and resistance of microorganisms to 
disinfections[13,32,33]. So, all these factors make E. faecalis 
as one of the major pathogens in the oral cavity, with a 
high risk of treatment failure because of its resistance to 
both antibiotics and antiseptics. Therefore, elimination of 
this harmful bacterium from oral ecosystem needs other 
solutions.
   As alternative to antibiotics and antiseptics, we have 
tested some EOs against oral multidrug-resistant E. faecalis, 
especially in biofilm state, which is the real existence state 
of this harmful bacterium in the oral cavity, and the reason 
for its ability to survive under severe conditions causing 
pathogenesis during chronic infections. Antimicrobial 
activity evaluation of studied EOs against E. faecalis strains 
was very interesting, whether in planktonic or biofilm state. 
When we compare the ability to total E. faecalis eradication 
of studied EOs with well-used endodontic antiseptics, 
we find these EOs are competitive, especially in biofilm 
state. In study realized by Sena et al.[34], it was found that 
chlorhexidine at 2% and NaOCl at 5.25% can eradicate E. 
faecalis, on condition when supplemented with mechanical 
agitation. While, some authors indicate that chlorhexidine 
and NaOCl show a low ability to eliminate E. faecalis[16]. For 
example, Arias-Moliz et al.[35] found that chlorhexidine at 
4% did not eradicate E. faecalis biofilm. So, we conclude that 
studied EOs are good alternative antiseptic which can be 
used instead of chlorhexidine or NaOCl, especially against 
E. faecalis biofilm.
   Comparison of the antimicrobial effect of studied EOs, 
using Student t-test at 95% confidence level (P<0.05), 
between sensitive and resistant strains have shown no 
difference in activity at planktonic state. While in biofilm 
state, Student t-test at 95% confidence level (P<0.05) show 
a significant difference between strains, where studied EOs 
were more effective against sensitive strains of E. faecalis 
than clinical ones. This could explain that biofilm formation 
was prevalent among isolates with MDR phenotype[36], as well 
as the slow metabolic rate of microorganisms in biofilms[37], 
and the extracellular matrix of the biofilm impede the 
effectiveness of many antimicrobials, which deters these 
agents to gain the protected cell inside[38]. We concluded 
that MDR strains of E. faecalis were less sensitive to EOs 
mainly due to their high ability to biofilm formation. But 
even if there is a mild resistance of biofilm to EOs, these 
antimicrobial agents remained effective, especially those of 
T. capitata and O. glandulosum.
   A huge number of studies that evaluate the antimicrobial 
activity of many EOs were published in recent years, from 
which some authors concluded that antimicrobial activity 
of EOs was strongly correlated with the content of terpenoid 
phenols such as carvacrol, eugenol and thymol and some 
other oxygenated monoterpenes such as nerol, linalool, 
α-terpineol, fenchol and terpinen-4-ol[18,39,40]. In this study, 
we have found the same remark, where chemical analyses of 
studied EOs showed that among the most active EOs against 
MDR E. faecalis strains, O. glandulosum, T. capitata, L. 
multifida, and A. verticillata EOs are constituted principally 
by terpenoid phenols, 41.62% thymol, 58.68% carvacrol, 57.75% 
carvacrol, and 50.13% thymol, respectively. While M. piperita 
was constituted principally by oxygenated monoterpenes, 
51.59% linalool. In the other hand, synergetic effect between 
all major compounds of EOs was reported in some studies, 
where EO was more antimicrobially active than its major 
compound that was responsible for activity. For example, 
in study realized by Veras et al.[41] they found that EO of 
Lippia sidoides was more effective against Staphylococcus 
aureus than thymol alone, its major compound. In addition, 
Mulyaningsih et al.[42] found a good synergetic effect between 
compounds of Eucalyptus globulus EO against multidrug-
resistant bacteria, Staphylococcus aureus and Enterococcus 
faecalis. As well as, multiple combinations between terpenes 
were effective against microorganisms[43], the use of the 
entire EO as antiseptic in mouthwash seems to be better than 
use of those terpenes alone, in both antimicrobial activity 
and natural treatment.
   In summary, the findings of this study indicate that EOs 
extracted from aromatic plants can be used in treatment of 
oral intractable infections caused by E. faecalis, especially 
persistent endodontic infections. Because of their high 
yield and strong antimicrobial activity in biofilm state, the 
activity of three Algerian medicinal plants O. glandulosum, 
T. capitata and A. verticillata as solution used in eradication 
of MDR pathogens from oral ecosystem seems to be very 
important in both medical and economical point of view.  
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Comments 
Background
   Enterococci are the commensal Gram-positive bacteria 
that inhabit in oral cavity, gastrointestinal tract and vagina 
of humans and animals. Enterococci are multidrug-resistant 
bacteria to most antimicrobial drugs used to treat human 
infections and they exhibit a considerable therapeutic 
challenges. E. faecalis is responsible for several oral 
pathologies, particularly, dental caries, dental abscess, 
periodontal infections etc. The secondary metabolites 
of plants, especially, EOs are one of the most important 
bioactive substances in medicinal plants. Possessing a good 
antimicrobial activity, EOs can replace treatments with 
antibiotics and disinfection using antiseptics.
  
Research frontiers
   Ten medicinal plants were studied in this research. The 
choice of plant species was based on their use by the local 
population against oral infections, such as periodontal 
infections and dental caries. Seven strains of E. faecalis have 
been selected for this study; two of them were American 
Type Culture Collection strains with codes ATCC 29212 and 
ATCC 49452 (sensitive to antibiotics). While the rest were 
multidrug-resistant strains, selected from  a collection 
of clinical E. faecalis strains obtained from patients with 
various oral infections, including apical periodontitis, 
chronic periodontitis, aggressive periodontitis, and 
cervicofacial cellulitis. Antimicrobial activity of EOs against 
planktonic E. faecalis strains assay and antimicrobial 
activity of EOs against E. faecalis strains in biofilm assay 
were done.
Related reports
   E. faecalis is the etiological causative agent where it’s 
responsible for serious complications. It is the fact that 
this bacterium possesses not only many virulence factors, 
but also an endogenous resistance to extreme ecological 
conditions and antimicrobials, allowing E.faecalis to tolerate 
harsh environmental conditions in some sites within oral 
cavity, especially in root canal. EOs have many interesting 
medicinal properties which can contribute to the treatment 
of intractable oral infections such as anti-inflammatory, 
anti-oxidant and stimulating the immune system response 
activities.
Innovations and breakthroughs
   EOs extracted from aromatic plants in this study can be 
used in treatment of oral intractable infections caused by E. 
faecalis, especially persistent endodontic infections. 
  
Applications
   EOs are good alternative antiseptics which can be used 
instead of chlorhexidine or NaOCl, especially against MDR E. 
faecalis biofilm. It might be applied to use in other virulence 
bacterial strains.
Peer review
   This study evaluated some EOs in treatment of intractable 
oral infections, principally caused by biofilm of multidrug-
resistant E. faecalis. The results of this study is useful for 
E. faecalis infection treatment. The high yield and strong 
antimicrobial activity of three Algerian medicinal plants EOs 
used in eradication of MDR pathogens from oral ecosystem 
may contribut to the medical treatment for oral intractable 
infections caused by E. faecalis.
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